SG Americas Securities’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.92M | Buy |
+16,915
| New | +$2.92M | 0.01% | 571 |
|
2025
Q1 | – | Sell |
-33,944
| Closed | -$4.67M | – | 3007 |
|
2024
Q4 | $4.67M | Buy |
33,944
+31,723
| +1,428% | +$4.37M | 0.02% | 324 |
|
2024
Q3 | $332K | Sell |
2,221
-3,887
| -64% | -$581K | ﹤0.01% | 1819 |
|
2024
Q2 | $833K | Buy |
6,108
+4,205
| +221% | +$573K | ﹤0.01% | 1286 |
|
2024
Q1 | $288K | Buy |
+1,903
| New | +$288K | ﹤0.01% | 1528 |
|
2023
Q2 | – | Sell |
-46,347
| Closed | -$4.97M | – | 1968 |
|
2023
Q1 | $4.97M | Buy |
46,347
+25,417
| +121% | +$2.73M | 0.06% | 238 |
|
2022
Q4 | $2.56M | Buy |
20,930
+19,838
| +1,817% | +$2.42M | 0.03% | 392 |
|
2022
Q3 | $113K | Buy |
+1,092
| New | +$113K | ﹤0.01% | 2477 |
|
2022
Q2 | – | Sell |
-942
| Closed | -$111K | – | 3040 |
|
2022
Q1 | $111K | Buy |
942
+142
| +18% | +$16.7K | ﹤0.01% | 2424 |
|
2021
Q4 | $108K | Sell |
800
-2,454
| -75% | -$331K | ﹤0.01% | 2746 |
|
2021
Q3 | $519K | Buy |
3,254
+727
| +29% | +$116K | ﹤0.01% | 2263 |
|
2021
Q2 | $332K | Buy |
+2,527
| New | +$332K | ﹤0.01% | 1915 |
|
2021
Q1 | – | Sell |
-1,971
| Closed | -$329K | – | 2898 |
|
2020
Q4 | $329K | Buy |
1,971
+804
| +69% | +$134K | ﹤0.01% | 2023 |
|
2020
Q3 | $180K | Buy |
+1,167
| New | +$180K | ﹤0.01% | 1844 |
|
2020
Q2 | – | Sell |
-2,213
| Closed | -$249K | – | 3139 |
|
2020
Q1 | $249K | Sell |
2,213
-1,758
| -44% | -$198K | ﹤0.01% | 1967 |
|
2019
Q4 | $552K | Sell |
3,971
-6,175
| -61% | -$858K | 0.01% | 1459 |
|
2019
Q3 | $977K | Sell |
10,146
-2,881
| -22% | -$277K | 0.01% | 1239 |
|
2019
Q2 | $1.5M | Buy |
13,027
+10,939
| +524% | +$1.26M | 0.01% | 1084 |
|
2019
Q1 | $246K | Buy |
2,088
+234
| +13% | +$27.6K | ﹤0.01% | 2122 |
|
2018
Q4 | $116K | Buy |
+1,854
| New | +$116K | ﹤0.01% | 2249 |
|
2018
Q3 | – | Sell |
-11,461
| Closed | -$762K | – | 2568 |
|
2018
Q2 | $762K | Buy |
+11,461
| New | +$762K | 0.01% | 1505 |
|